An extended overall survival analysis of pemetrexed and carboplatin with or without pembrolizumab as first-line therapy for advanced non-squamous non-small cell lung cancer

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Afzal, Muhammad Zubair, Dragnev, Konstantin H., Shirai, Keisuke
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Editorial Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6462590/
https://ncbi.nlm.nih.gov/pubmed/31032332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.03.09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars